Financhill
Back

Galapagos NV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
44

GLPGF
Galapagos NV

Last Price:
22.60
Seasonality Move:
-5.61%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
44
Galapagos NV (GLPGF) is a Sell

Is Galapagos NV a Buy, Sell or Hold?

  • The current Galapagos NV [GLPGF] share price is $35.52. The Score for GLPGF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • GLPGF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLPGF Stock Price Chart

What is Galapagos NV's stock price today?

  • The Galapagos NV share price today is $35.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLPGF is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

GLPGF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 51.6 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.52 - 35.52) Sell
Bollinger Bands (100): (35.02 - 36.02) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

GLPGF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.52 Sell
20-day SMA: 35.52 Sell
50-day SMA: 35.52 Sell
200-day SMA: 35.05 Buy
8-day EMA: 35.52 Sell
20-day EMA: 35.52 Sell
50-day EMA: 35.49 Buy
200-day EMA: 36.04 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Galapagos NV Earnings Growth & GLPGF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Galapagos NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):